Skip to Main Content

Paper Details

Re: Kerrington Powell, Michael C. Burns, Vinay Prasad. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. Eur Urol. 2023;83:101-2.
Eur Urol
0
2023
Author NameAffiliation
Alberto BrigantiIRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University
Giorgio GandagliaIRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University
  • 1 - 2

Datasets

Release 1.2